Figure 2.
Changes in plasma free fatty acids (A), plasma glucose (B), and C-peptide (C) and C-peptide–to–glucose ratio (D) during 48-h intralipid infusion in obese subjects with KPDM, type 2 diabetic subjects with hyperglycemia, and obese nondiabetic control subjects. Values are means ± SE. ●, KPDM; ○, hyperglycemia; ▾, control.
